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Abstract 
Objective: Despite advances in medical care, survival to discharge and full neurological 
recovery after cardiac arrest remains < 20% following CPR.  An alternate approach to traditional 
CPR is extracorporeal cardiopulmonary resuscitation (E-CPR), which places patients on ECMO 
during CPR, and provides immediate cardiopulmonary support when traditional resuscitation has 
been unsuccessful.  Here, we report results from E-CPR at our institution.   
Methods:  Between 2010 and June 2014, a total of 107 adult ECMO procedures were performed 
at our institution.  Patient demographics, survival to discharge, and neurological recovery of 
patients that underwent E-CPR were retrospectively analyzed with IRB approval. 
Results:  23 patients (15 males and 8 females, mean age 46 ± 12 years) underwent E-CPR.  All 
patients who met criteria were placed on 24-hour hypothermia protocol (target temperature 33 
0C) with initiation of ECMO.  The mean duration of ECMO support was 6.2 ± 5.5 days.  Nine 
patients died while on ECMO from the following causes: anoxic brain injury (4), stroke (4), and 
bowel necrosis (1).  Two patients with anoxic brain injury on E-CPR donated multiple organs for 
transplant.  The survival to discharge rate was 30% (7/23 patients) with ~100% full neurological 
recovery. 
Conclusions:   The E-CPR procedure provided reasonable patient recovery.   E-CPR also 
allowed for neurological recovery and made multi-organ procurement possible.  Based on the 
above survival rates, E-CPR should be considered when determining the optimal treatment path 
for patients who need cardiopulmonary resuscitation.  The proper use of E-CPR improved 
hospital outcomes for the in-hospital cardiac arrested patients. 
Word Count: 240/250 
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Title: Saving Life and Brain with Extracorporeal Cardiopulmonary Resuscitation (E-CPR).  A 
Single Center Analysis of In-Hospital Cardiac Arrests. 
 
Central Message: E-CPR offers means of resuscitation for patients refractory to traditional 
CPR.  E-CPR improved hospital outcomes for patients who suffered an in-hospital cardiac arrest.  
 
Perspective: Results from E-CPR at our institution show a ~30% hospital discharge rate with no 
major neurological consequence.  E-CPR also made multi organ procurement possible in non-
survivors through ECMO support of end-organ function.  Based on these statistics, E-CPR 
should be considered when determining a treatment path for patients who suffer an in-hospital 
cardiac arrest.  
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List of abbreviations 
ALT: alanine aminotransferase. 
AMI: acute myocardial infarction. 
APACHE II: acute physiology and chronic health evaluation II. 
AST: aspartate aminotransferase. 
CPR: cardiopulmonary resuscitation. 
ECMO: extracorporeal membrane oxygenation. 
ICU: intensive care unit. 
E-CPR: extracorporeal cardiopulmonary resuscitation. 
MELD: model for end-stage liver disease. 
SAPS II: simplified acute physiology score II. 
SOFA: sequential organ failure assessment score. 
VTach/VFib: ventricular tachycardia or ventricular fibrillation. 
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Introduction 
Cardiopulmonary resuscitation (CPR) is a widely known procedure used to save lives 
when patients undergo cardiac arrest.  However, despite being extensively taught and used, CPR 
remains ineffective.  A meta-analysis has shown that 23.8% of out-of-hospital CPR patients 
survive to admission, and a mere 7.6% of these patients ultimately survive to be discharged from 
the hospital [1].  Even when CPR takes place in hospital setting, the overall survival rates are not 
encouraging.  It is reported that <50% of patients survive CPR [2-4], while  < 20% of patients 
survive to discharge [2, 4].  These results suggest that when traditional CPR is not effective, 
alternate means of resuscitation are necessary.  
 As ECMO rises in popularity and use, there has been increasing interest in its viability 
and success when used during CPR (E-CPR).  E-CPR provides a method to stabilize 
hemodynamics and provide end-organ perfusion when traditional CPR is inadequate and the 
cause of cardiac arrest is reversible.  While many studies have assessed the efficacy of E-CPR in 
pediatric populations [5-7], fewer have investigated it in an adult population.  The studies of 
adult populations have assessed the success of E-CPR in adult populations by mortality, and 
many have not taken end-organ function into account.  
In a study that assessed the survival benefits of E-CPR compared to conventional CPR 
after a witnessed arrest, E-CPR provided a significantly higher return of spontaneous circulation, 
and a ~ 20% increase in survival rate at discharge [8].  Further studies on E-CPR have shown an 
increased rate of survival at 1-year [8], and 2-years [9] after discharge when compared to 
conventional CPR.  Many of these studies on adult E-CPR have taken place under optimal 
conditions in institutions that have designated teams of E-CPR specialists, ready to cannulate 
patients as a part of the Code Team [8-10].   
 7 
Through this investigation, there will be greater understanding of the benefits to be 
gained from E-CPR, such as successful hospital discharge with limited neurological damage, or 
organ procurement in non-survivors.  If shown to be effective, this study will assert that E-CPR 
should be considered during in-hospital cardiac arrests.  
Methods 
 From June 2010 through July 2014 a total of 107 adult ECMO procedures were done at 
our institution.  Of those 107 procedures, 23 patients had E-CPR after failing to respond to 
traditional CPR.  All E-CPR candidates were in-patients with a witnessed arrest, and the ECMO 
team was notified less than 20 minutes following the initial arrest.  Our institution’s E-CPR 
protocol was applied to all patients as follows; the attending physician in charge of a Code Blue 
determined whether ECMO was feasible within 20 minutes of unsuccessful resuscitation based 
on the exclusion criteria: patient’s age > 70 years old; the presence of a patient’s ‘Do Not 
Resuscitate’ orders; whether the patient has an uncorrectable baseline disease such as terminal 
cancer, advanced coronary artery disease, or a previous neurological deficit; if the patient has 
uncontrolled sepsis or bleeding.   The code team notified the attending physician on call in the 
surgical cardiovascular ICU, who immediately evaluated the patient’s risks and benefits.  If all 
parties were in agreement that ECMO was necessary, the patient was cannulated at the bedside.  
Perfusionists were called in to set up the ECMO circuit.  CPR was continued until ECMO was 
initiated; all E-CPR patients were started on veno-arterial ECMO.  The cannulation procedure 
was followed as outlined by Lamb and colleagues in order to minimize the risk of excessive 
bleeding and limb ischemia [11].  Patients who underwent CPR, but no longer required CPR 
during ECMO cannulation were excluded from this study.  In house attending intensivists from 
the surgical cardiovascular ICU (cardiothoracic surgeons) were responsible for ECMO 
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placement in all patients.  Their coverage spanned all regular daytime working hours, and 4/7  
nights with a nocturnist intensivist.  Perfusionists were responsible for ECMO circuit setup, and 
were available in-house during all regular daytime hours. Perfusionsists were also on call during 
off-hours.  
 In our institution, 100% of the patients treated with E-CPR were placed on a standard 
hypothermia protocol at 33 oC for 24 hours to enhance neurological protection.  Target 
temperature management was met in all patients via an Artic Sun cooling machine.  Clinical 
neurological assessment was continued with both cooling and rewarming phases.  If a patient had 
a focal neurological deficit, uncontrolled seizures, or cerebral oximetry desaturation, the patient 
was sent for a CT scan immediately—regardless of whether the patient was on or off ECMO.  
Once rewarmed, any persistent coma or neurological deficit necessitated a CT scan.  Following a 
positive CT scan for suspected anoxic brain injury, neurology was consulted to evaluate 
neurological outcomes, and if necessary, a cerebral perfusion scan was performed on ECMO to 
diagnose potential brain death.  If the patient was deemed to be non-recoverable, terminal ECMO 
decannulation was performed after consultations with the family, palliative care team, and the 
organ procurement agency.  
Patient demographics, E-CPR survival, survival to discharge, and organ and neurological 
recovery were retrospectively analyzed through an Institutional Review Board approved database 
(Thomas Jefferson University approval #10D.155).  The acute physiology and chronic health 
evaluation II (APACHE II) [12], model for end stage liver disease (MELD) [13], simplified 
acute physiology score II (SAPS II) [14], and sequential organ failure assessment (SOFA) [15] 
scores were calculated based on the pre-ECMO, peri-ECMO and post-ECMO data.  
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Statistical analyses were performed using Chi-square or Fisher’s exact tests for 
categorical variables and Student’s t-tests for continuous variables, as appropriate, to identify the 
risk factors for ECMO death.  Similar analyses were performed to identify the risk factors for 
hospital death among the ECMO survivors.  Our sample size was too small for a multivariate 
analysis. The results were expressed as number with percentage, or mean ± standard deviation.  
P-values < .05 were considered to be significant.  
Results 
Patients: The 23 patients who received E-CPR at our institution consisted of 15 males and 8 
females with a mean age of 46 ± 12 years.  The primary diagnoses leading to E-CPR in the 
patients were acute myocardial infraction (AMI) (n=9), non-ischemic malignant ventricular 
tachy-arrhythmia (n=5), myocarditis (n=2), acute pulmonary embolus (n=2), hypothermia (n=2), 
acute rejection (n=1), drug induced cardiac arrest (n=1), and post-cardiotomy failure (n=1).  The 
initial cardiac rhythms in E-CPR patients were ventricular tachycardia or fibrillation (n=8) or 
pulseless electrical activity (n=15).  All patients with a ventricular tachyarrhythmia received 
electrical defibrillation or cardioversion as appropriate; however, all 8 patients deteriorated into 
pulseless electrical activity or cardiac arrest prior to the establishment of ECMO.  E-CPR was 
performed in the intensive care unit (ICU) (n=9), catheterization lab (n=7), emergency 
department (n=5), and operating room (n=2).  Of the patients who had an AMI, 2 patients had a 
percutaneous coronary intervention (PCI) prior to ECMO.  The average time of CPR prior to 
ECMO was 54 ± 30 min.  With the exception of 2 patients, all underwent femoral cannulation as 
described previously. The remaining patients had an open sternum and were cannulated centrally 
between the aorta and the right atrium.  
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ECMO survival: Following E-CPR, the average time on ECMO was 6.2 ± 5.5 days. 14 patients 
(61%) survived ECMO and 9 patients (39%) died while on ECMO (Figure 1).  The causes of 
death in patients who died on ECMO were anoxic brain injury (n=4), stroke (n=4), and bowel 
necrosis (n=1).  Among the patients who suffered an anoxic brain injury, 2 donated multiple 
organs for transplant.  Among the 14 ECMO survivors, 13 had unchanged or improved status in 
at least one organ (liver function improved or unchanged in 13, kidney function improved or 
unchanged in 13, and lactate improved in 12, unchanged in 1 as shown in Table 1).  Acute renal 
failure occurred during ECMO in 5 patients.  All 5 of these patients were managed by CVVHD 
during ECMO treatment.  Among the patients who survived ECMO, two were post-cardiotomy 
failure status post coronary artery bypass graft.  Of the variables tested pertaining to patient 
demographics, clinical risk factors, and pre-ECMO laboratory data, only pre-ECMO creatinine 
levels (p=0.022), and pre-ECMO pH (p=0.039) correlated with ECMO survival (Table 2).  No 
verified ICU or disease-specific risk scores pre-ECMO had a correlation with E-CPR survival 
(Table 2).  On ECMO, cardiac (myocardial standstill, [p=0.034]), and any neurological 
complications (stroke and anoxic brain injury) (p=0.001) were factors correlated with death 
during ECMO (Table 3).  Of the risk scores calculated with data from 24 hours after ECMO 
initiation, the MELD, SOFA, and APACHE II scores were correlated with ECMO survival after 
E-CPR (Table 4).  Isolated data from 24 hours after ECMO initiation associated with ECMO 
survival included: lactate levels (survivors: 3.7 ± 2.5; non survivors: 8.8 ± 5.3; p=0.015), 
bicarbonate levels (survivors: 27.1 ± 2.7; non survivors: 22.6 ± 1.3; p= 0.0001), and creatinine 
levels (survivors: 1.3 ± 0.5; non survivors: 1.9 ± 0.5; p= 0.007).  
Hospital Survival:  Seven of the 14 patients (50%) who survived ECMO were successfully 
discharged from the hospital, yielding a hospital survival rate of 30% (7/23) (Figure 1).  The 
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causes of death in the seven patients who died following successful ECMO decannulation were 
anoxic brain injury post cardiac arrest despite cooling and ECMO (n=2), stroke (n=1), brain 
death from unknown reason (n=2), sepsis (n=1), and AMI from the non-revascularized coronary 
artery (n=1).  All causes of death appeared to be related to the initial insult leading to cardiac 
arrest.  Of the variables tested pertaining to patient demographics, clinical risk factors, pre-
ECMO laboratory data and/or disease-specific risk scores, only pre-ECMO bilirubin levels were 
correlated with hospital survival (p=0.040) (Table 5).  No pre-ECMO ICU or disease-specific 
risk scores were found to correlate with hospital survival after E-CPR.  Risk scores taken 24 
hours after the initiation of ECMO were not found to have a significant correlation with hospital 
survival after E-CPR.  The only isolated data from 24 hours after ECMO initiation associated 
with hospital survival was 24-hour PaO2 (survivors: 197 ± 115; non survivors: 248 ± 110; 
p=0.037) which had an association with hospital survival.  1 patient who developed acute renal 
failure survived ECMO but died before discharge. The overall length of the hospital stay after E-
CPR was 43 ± 28 days.  All patients who were discharged from the hospital did not demonstrate 
any gross neurological deficits during a follow up visit 4-6 weeks following discharge from a 
rehabilitation facility.  No patients discharged from the hospital were bed-ridden.  There were no 
limitations of daily activity at 6-8 week follow-ups from the date of discharge.   
Discussion 
 CPR is a technique used around the world to allow patients a second chance at life.  
When traditional CPR fails in a hospital setting, there are alternative procedures for resuscitation.  
With the popularity of ECMO growing, and the number of ECMO trained individuals increasing, 
E-CPR can provide a method by which a patient can be resuscitated when traditional CPR is 
ineffective.  
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The present study assesses the survival rate, neurological recovery and end organ 
function of E-CPR patients in our institution, while attempting to identify risk factors for patients 
undergoing E-CPR.  When compared to previously published CPR survival rates (<20%), our E-
CPR survival rate demonstrated reasonable recovery for arrested patients [2, 4]. 
Technical issues of cannulation during E-CPR remain an issue that has been discussed in 
the literature. A previous study showed an ischemia complication rate of 30% [27]. However, 
using our E-CPR technique, including standard peripheral cannulation and the use of distal 
profusion catheters in all patients, the risk of lower leg ischemia complications has been lowered 
dramatically. 
Our study supports a number of findings from an E-CPR study done in pediatric patients, 
which demonstrated that patient demographic factors such as age, weight and sex do not effect 
survival [6], and another paper indicating a correlation with duration of ECMO [16].  Our study 
also partially agrees with major conclusions from previous studies of adult E-CPR patients, 
which indicate that a state of acidosis is correlated with poor E-CPR outcomes [20].  However, 
our results contradicted the findings of a number of other studies, including those which claimed 
that low inotrope levels, low pre-ECMO lactate levels, shorter CPR duration, and low pre-
ECMO SOFA scores were associated with favorable outcomes in E-CPR patients [17-19].  We 
found no association between any pre-ECMO risk scores (MELD, SAPS II, SOFA, APACHE II) 
and ECMO survival.  Different from previous reports, the current study investigated end-organ 
function to determine if ECMO allowed a patient’s vital organs to remain in functional 
condition. Many prior studies have not completed a similar examination. 
Interestingly, some of the strongest correlations found in the present study relate to values 
taken 24 hours after the initiation of ECMO.  The MELD, SOFA and APACHE II scores taken at 
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this time point significantly predicted ECMO survival, with a higher score yielding a worse 
prognosis.  Knowing this, along with completing a neurological evaluation, provides clinicians 
with a benchmark to form a prognosis of whether the patient will survive ECMO following E-
CPR.  Rather than having to wait a number of days, by calculating MELD, SOFA and APACHE 
II scores 24 hours after E-CPR, physicians and families can gain better insight into the ultimate 
chances the patient has at survival. 
Neurological complications remain a major cause of patient death.  Although one patient 
who developed a stroke during ECMO survived ECMO, the majority of patients who suffered 
from anoxic brain injuries or strokes during ECMO developed clinical brain death.  Despite the 
nature of ECMO, and the hypothermia protocols initiated, we found that 8 patients (35%) had 
clinical brain death while on ECMO, and an additional four patients (17%) had major 
neurological events after ECMO removal, thus limiting their survival.  The timing and causative 
factors for the neurological events were unclear, and neurological protection remains important 
in improving the survival after E-CPR.  That being said, the neurological recovery among 
hospital survivors was encouraging.  All of the hospital survivors in our study were successfully 
discharged without any gross neurological deficits.  ECMO treatment has been associated with 
the risk of neurological complications, with E-CPR raising that risk even further [21-22].  Prior 
studies have compared the efficacy of E-CPR to conventional CPR in preventing long-term 
neurological damage, and have shown that E-CPR is significantly better at neurological 
protection than conventional CPR [9].  Recently, a single center observational study assessing 
the use of aggressive E-CPR combined with hypothermia for cardiac arrest patients demonstrated 
similar results of full neurological recovery for the E-CPR survivors [28].  
 14 
Organ preservation is another benefit of ECMO treatment.  In all but one of the E-CPR 
survivors, organ function was either improved or unchanged (Table 1).  This is a phenomenon 
that has previously been associated with beneficial outcomes from ECMO treatment [23].  
Furthermore, in two patients who did not survive ECMO and died of anoxic brain injury, solid 
organs were harvested for transplantation.  The procurement and sustained function of organs 
from ECMO non-survivors is a distinct benefit to be gained from ECMO, as reported previously 
by our group and others [24-26].  Results from our current study demonstrated the efficacy of E-
CPR in also allowing organs to be harvested for transplantation in patients who have suffered an 
anoxic brain injury.  Organ procurement is clearly a topic that has many potential ethical 
implications, though, and this study does not thoroughly investigate the boundaries that 
physicians should adhere to when attempting to procure an organ for transplant.  
 This study was limited due to its retrospective nature, and small sample size.  Many 
patients who received CPR at our institution during the study period were not candidates for 
ECMO due to their age, various comorbidities, and access to ECMO circuits.  In the present 
setting at our institution, the ECMO team is not a regular part of the Code Team.  This leads to 
limitations as to when E-CPR can be performed due to variable availability of attending 
physicians, perfusionists and ECMO circuits.  This is a setting that differs from that described in 
a number of previous reports on E-CPR [8-10].  Ideally, our E-CPR sample could have been 
compared to an internal control group, but our hospital CPR records are incompletely 
documented, and the CPR patient population differed from ours.  While there were nearly 450 
Code Blues at our institution during this time period, only 23 patients were given E-CPR.  This 
may have led to bias as to who was treated with E-CPR rather than conventional CPR. 
Conclusion 
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E-CPR provides a viable alternative to traditional CPR for patients refractory to 
conventional resuscitation measures.  E-CPR should be strongly considered when the materials 
and personnel are available, and patients are unresponsive to conventional CPR.  The proper use 
of E-CPR may greatly improve hospital outcomes for patients who suffer an in-hospital cardiac 
arrest.  
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Table 1: Organ function before and after ECMO (ECPR Survivors) 
 
 
Pre-ECMO Post-ECMO 
Creatinine  (mg/dl) 1.1 ± 0.4 1.1 ± 0.3 
AST (IU/L) 147 ± 177 133 ± 178 
Lactate (mmol/L) 7.0 ± 5.4 2.1 ± 1.5 
Murray score 2 ± 1 1 ± 1 
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Table 2: Patient demographics, clinical risk factors, laboratory data, and risk scores before E-
CPR, comparing ECMO survivors to ECMO non-survivors. 
 ECMO Survivors 
N=14 
ECMO Non-Survivors 
N=9 
p 
Pre ECMO demographics 
   
Age (yr.) 46 ± 10 45 ± 16 0.881 
Male gender 9 (64%) 6 (67%) 0.907 
Body weight (kg) 84 ± 22 88 ± 19 0.637 
Body surface area (m2) 1.96 ± 0.27 2.02 ± 0.25 0.592 
Body mass index (kg/m2) 28 ± 6.2 29 ± 4.5 0.712 
Clinical risk factors 
   
Smoking history 5 (36%) 3 (33%) 0.907 
Coronary artery disease 5 (36%) 4 (44%) 0.675 
Diabetes  2 (14%) 4 (44%) 0.108 
Laboratory data    
White blood cell count (B/L) 13.8 ± 8.3 12.8 ± 5.9 0.742 
Hemoglobin (g/dl) 11.5 ± 3.4 12.2 ± 3.1 0.605 
Platelet count (B/L) 206 ± 125.4 180.4 ± 99.3 0.129 
PaO2 (mm Hg) 164 ± 144 147 ± 153 0.802 
PaCO2 (mm Hg) 45 ± 13 47 ± 17 0.772 
HCO3 (mmol/L) 19 ± 5.8 15 ± 7.1 0.217 
Creatinine (g/dl) 1.1 ± 0.4 1.7 ± 0.7 0.022 
Bilirubin (mg/dl) 0.9 ± 0.8 0.7 ± 0.8 0.589 
AST (IU/L) 147 ± 177 595 ± 889 0.213 
ALT (IU/L) 95 ± 108 392 ± 588 0.182 
Lactate (mmol/L) 7.0 ± 5.4 13.7 ± 9.3 0.072 
pH 7.24 ± 0.17 7.05 ± 0.21 0.039 
CPR time before ECMO (min) 52 ± 28 57 ± 35 0.693 
Initial rhythm: VAC/VFib 2 (14%) 6 (67%) 0.010 
Pre-ECMO Scores    
Pre-ECMO MELD 10.0 ± 3.6 17.6 ± 11.6 0.094 
Pre-ECMO SAPS II 61.6 ± 8.1 56.3 ± 20.6 0.639 
Pre-ECMO SOFA 14.3 ± 1.1 13.5 ± 2.2 0.388 
Pre-ECMO APACHE II 33.1 ± 8.1 35.4 ± 9.2 0.590 
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Table 3: Complications during ECMO. 
 
ECMO 
Survivors 
N=14 
ECMO Non-
Survivors 
N=9 
p 
Time on ECMO support (days) 7.8 ± 6.3 3.6 ± 2.1 0.033 
Any neurological complications 1 (7%) 8 (89%) <0.001 
Anoxic brain injury  0 4 (44%) 0.006 
Stroke 1 (7%) 4 (44%) 0.034 
Myocardial stunning 1 (7%) 4 (44%) 0.034 
Hemothorax 2 (14%) 1 (11%) 0.825 
Massive hemoptysis 2 (14%) 0 0.235 
Pneumonia 2 (14%) 0 0.235 
Cannula Site Bleeding 5 (36%) 2 (22%) 0.493 
Liver failure 1 (7%) 2 (22%) 0.295 
Ischemic bowel  0 1 (11%) 0.202 
Leg ischemia  0 0 NA 
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Table 4: Risk scores 24 hours after E-CPR.  
 
 
ECMO Survivors 
N=14 
ECMO Non-Survivors 
N=9 
p 
MELD 24hr of ECMO 15.4 ± 4.1 22.2 ± 6.3 0.011 
SAPS II 24hr of ECMO 48.1 ± 7.8 53.0 ± 4.2 0.285 
SOFA 24hr of ECMO 11.4 ± 1.9 14.5 ± 2.7 0.031 
APACHE II 24hr of ECMO 22.8 ± 4.1 29.8 ± 6.7 0.013 
  
 20 
Table 5: Patient demographics of ECMO survivors, comparing hospital survivors to hospital 
non-survivors. 
 Hospital Survivors 
 
N=7 
Hospital Non-
Survivors 
N=7 
p 
Pre ECMO demographics 
   
Age (yr.) 50 ± 8 43 ± 10 0.148 
Male gender 4 (57%) 5 (71%) 0.577 
Body weight (kg) 87 ± 28 80 ± 16 0.604 
Body surface area (m2) 1.97 ± 0.34 1.95 ± 0.20 0.895 
Body mass index (kg/m2) 30 ± 7.3 26 ± 4.9 0.339 
Clinical risk factors 
   
Smoking history 2 (29%) 3 (43%) 0.577 
Coronary artery disease 3 (43%) 2 (29%) 0.577 
Diabetes  2 (29%) 0  0.127 
Laboratory data    
White blood cell count (B/L) 13.9 ± 10.5 13.6 ± 6.1 0.942 
Hemoglobin (g/dl) 11.4 ± 3.9 11.5 ± 3.2 0.988 
Platelet count (B/L) 218 ± 154.0 194 ± 99.9 0.735 
PaO2 (mm Hg) 129 ± 154 198 ± 136 0.426 
PaCO2 (mm Hg) 42 ± 14 47 ± 14 0.580 
HCO3 (mmol/L) 18 ± 5.9 19 ± 6.1 0.776 
Creatinine (g/dl) 1.1 ± 0.5 1.1 ± 0.2 0.999 
Bilirubin (mg/dl) 0.2 ± 0.2 1.3 ± 0.9 0.040 
AST (IU/L) 45 ± 24 207 ± 206 0.132 
ALT (IU/L) 37 ± 22 130 ± 127 0.161 
Lactate (mmol/L) 5.3 ± 4.6 8.3 ± 6.0 0.382 
pH 7.25 ± 0.21 7.23 ± 0.14 0.842 
CPR time before ECMO (min) 56 ± 34 44 ± 16 0.524 
Initial rhythm: VTach/VFib 1 (14%) 1 (14%) 1.000 
Pre ECMO scores    
Pre-ECMO MELD 10.6 ± 3.9 9.8 ± 3.5 0.789 
Pre-ECMO SAPS II 53.0 ± 0 63.8 ± 7.5 0.063 
Pre-ECMO SOFA 14.0 ± 1.0 14.4 ± 1.1 0.666 
Pre-ECMO APACHE II 35.7 ± 9.9 30.0 ± 4.7 0.237 
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Scores 24hr after ECMO    
MELD 24hr of ECMO 12.5 ± 4.3 17.0 ± 3.1 0.095 
SAPS II 24hr of ECMO 46.3 ± 6.7 50.7 ± 9.9 0.533 
SOFA 24hr of ECMO 11 ± 0 11.5 ± 2.3 0.607 
APACHE II 24hr of ECMO 22.0 ± 4.69 23.4 ± 4.0 0.591 
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Figure 1.  ECMO survival after E-CPR and hospital survival. 
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